Brewin Dolphin Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Brewin Dolphin Wealth Management's GILD Position: Q2 2022 in Review
Brewin Dolphin Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2022 at 300 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #241.
Brewin Dolphin Wealth Management first reported a position in GILD in Q3 2017 and has held it in 20 quarters since. The position peaked at $834K in Q3 2017. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.
- Brewin Dolphin Wealth Management held 300 shares of Gilead Sciences worth $19K as of Q2 2022.
- Brewin Dolphin Wealth Management left its Gilead Sciences share count unchanged in Q2 2022.
- Gilead Sciences made up ﹤0.01% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #241 holding.
- Brewin Dolphin Wealth Management first reported a position in Gilead Sciences in Q3 2017 and has held it in 20 quarters since.
- Brewin Dolphin Wealth Management's Gilead Sciences position peaked at $834K in Q3 2017.
- 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.
Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.